The purpose of this trial is to discover whether providing feedback to patients from a device that records when and how well a patient uses a Seretide Diskus inhaler will lead to:

• Improved compliance with prescribed inhaler use
• Improved technique of inhaler use
• A reduction in respiratory health related outcomes caused by poor inhaler compliance and usage.
• An improvement in patient quality of life scores

Inclusion Criteria:

• Must be 18 years old or above
• Capable of understanding and willing to provide voluntary informed consent before any protocol specific procedures are performed
• Capable of understanding and complying with the requirements of the protocol, and demonstrating a willingness to attend for all required visits.
• Able and willing to take inhaled medication.
• Have a valid prescription for use of a Seretide diskus inhaler or already using a Seretide diskus inhaler.
• Have a history of regular attendance in the pharmacy in which they are recruited which will be demonstrated by the subject having collected three prescriptions for any medication in that pharmacy in the six months preceeding their recruitment to the study.

Exclusion Criteria:

• Patient expressly reports that their physician has indicated that they will not be continuing to receive Seretide over the next 6 months